Is a complete TSXV/MRVL research report available?

Question

Accepted Answer

No complete published report is available for tsxv/MRVL (TSXV/MRVL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	8.8M
Net income (ttm)	-1.4M
EPS (ttm)	-CA$0.02
Shares out	63M
Volume	1,000
Beta	0.59

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 9.8M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA57384M1077
Last refreshed	2026-09-11
Market cap	CAD 8.8M
Price	CAD 0.14
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	tsxv/MRVL
Website	https://marvelbiotechnology.com

Metric	Value
Earnings Yield	-15.77%
FCF yield	-8.83%
P/B ratio	-3.23x

Metric	Value
Net Income	CAD -1.4M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Profitable Quarters	CAD 1
ROA	-172.1
Roa5y	-136.2
ROCE	63.43

Metric	Value
Cagr1y	-42.88%
Cagr3y	25.99%
Cagr5y	-6.89%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth Years	0x

TSXV/MRVL (TSXV/MRVL)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/MRVL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/MRVL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TSXV/MRVL

Frequently asked questions

Metric	Value
Assets	CAD 471,733
Cash	CAD 434,800
Current Assets	CAD 471,733
Current Liabilities	CAD 2.6M
Debt	CAD 1.4M
Debt FCF	CAD -1.79
Equity	CAD -2.7M
Interest Coverage	-4.25
Liabilities	CAD 3.2M
Long Term Assets	CAD 0
Long Term Liabilities	CAD 624,000
Net Cash	CAD -961,200
Net Cash By Market Cap	CAD -10.89
Tangible Book Value	CAD -2.7M
Tangible Book Value Per Share	CAD -0.04
WACC	8.88

Metric	Value
Current ratio	0.18
Net Working Capital	CAD -1.8M
Quick ratio	0.18
Working Capital	CAD -2.1M

Metric	Value
1Y total return	-42.86%
200-day SMA	0.16
3Y total return	100%
50-day SMA	0.16
50-day SMA vs 200-day SMA	50over200
5Y total return	-30%
All Time High	0.4
All Time High Change	-65%
All Time High Date	2025-08-29
All Time Low	0.01
All Time Low Change	1,300%
All Time Low Date	2023-10-02
ATR	0.01
Beta	0.59
Beta1y	0.1
Beta2y	-0.01
Ch YTD	3.7
High	0.14
High52	0.26
High52 Date	2025-09-22
High52ch	-45.1%
Low	0.14
Low52	0.12
Low52 Date	2026-03-11
Low52ch	21.74%
Ma50ch	-10.94%
Price vs 200-day SMA	-9.91%
RSI	38.59
RSI Monthly	47.47
RSI Weekly	44.16
Sharpe ratio	-0.1x
Sharpe Ratio3y	0.64x
Sortino ratio	-0.11
Sortino Ratio3y	1.05
Total Return	-29.36%
Tr YTD	3.7
Tr1m	-15.15%
Tr1w	-6.67%
Tr3m	-28.21%

Metric	Value
Float	49,404,883%
Shares Insiders	20.26%
Shares Institutions	8.77%
Shares Out	63,028,290
Shares Qo Q	6.15%
Shares Yo Y	29.36%

Metric	Value
Adjusted FCF	CAD -836,589
Adjusted OCF	-836,589
Average Volume	46,571.25x
Bv Per Share	-0.04
Ch1m	-15.15
Ch1w	-6.67
Ch1y	-42.86
Ch3m	-28.21
Ch3y	100
Ch5y	-30
Ch6m	-3.45
Change	0%
Change From Open	0
Close	0.14
Days Gap	0
Dollar Volume	140
Earnings Date	2026-11-27
EBIT	CAD -1.3M
EPS	CAD -0.02
F Score	2
FCF	CAD -778,838
FCF EV Yield	-7.96x
FCF Per Share	CAD -0.01
Financing CF	824,622
Fiscal Year End	July
Is Primary Listing	1
Last Earnings Date	2025-11-28
Last Report Date	2026-04-30
Ma150	0.16
Ma150ch	-11.45%
Ma20	0.15
Ma20ch	-8.38%
Net CF	45,784
Next Earnings Date	2026-11-27
Open	0.14
Price Date	2026-09-10
Relative Volume	0.02x
Share Based Comp	57,751
Tr6m	-3.45%
Volume	1,000